On the role of 3',5'-cyclic amp phosphodiesterase in insulin action on rat liver and adipose tissue.
D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D000818:Animals; D001645:Biguanides / Q000494:pharmacology; D002467:Cell Nucleus / Q000187:drug effects / Q000201:enzymology; D000242:Cyclic AMP; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology*; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D009539:Nicotinic Acids / Q000494:pharmacology; D010080:Oxazoles / Q000494:pharmacology; D010477:Perfusion; D010727:Phosphoric Diester Hydrolases / Q000502:physiology; D010744:Phosphoric Monoester Hydrolases / Q000502:physiology*; D011453:Prostaglandins / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D013453:Sulfonylurea Compounds / Q000494:pharmacology; D014044:Tolbutamide / Q000494:pharmacology
D001645:Biguanides; D007328:Insulin; D009539:Nicotinic Acids; D010080:Oxazoles; D011453:Prostaglandins; D011720:Pyrazoles; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D000242:Cyclic AMP; D010744:Phosphoric Monoester Hydrolases; D010727:Phosphoric Diester Hydrolases